Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4
Monthly follow-ups: 15-20 minutes (check weight, side effects, titrate dose if needed, provide encouragement)
Understanding these mechanisms matters because effective supplements target either central nausea signaling, gastric motility, or both
Access this article Similar content being viewed by others References Heerspink HJL, Perkins BA, Fitchett DH, Husain M, Cherney DZI
For more detail about the 2003 survey, see the Survey Methodology section of that years report
In the GLP-1 market, the differentiating factor is now whether companies can develop and manage a system capable of delivering a drug consistently to the patients who need it